---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-309012"
form_type: "8-K"
ticker: "SGMO"
cik: "0001001233"
company_name: "SANGAMO THERAPEUTICS, INC"
filed_at: "2026-07-20T20:44:31+00:00"
generated_at: "2026-07-20T20:45:20.673893+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.9
calibrated_materiality_score: 0.9
confidence: "high"
source: SEC EDGAR
---

# Sangamo Therapeutics receives Nasdaq delisting denial; bankruptcy court approves asset sale bidding procedures

## Summary
- Bankruptcy court approved asset sale bidding procedures; bid deadline Aug 4, auction Aug 10, sale hearing Aug 20.
- Nasdaq Hearings Panel denied listing continuation; company will not appeal; expects Form 25 delisting.
- Stock suspended from Nasdaq since May 5, 2026; currently trades on OTCQB under symbol SGMOQ.
- Company filed Chapter 11 on June 23, 2026; continues as debtor-in-possession under court jurisdiction.

## SEC filing metadata
- accession: 0001193125-26-309012
- form_type: 8-K
- ticker: SGMO
- cik: 0001001233
- company_name: SANGAMO THERAPEUTICS, INC
- filed_at: 2026-07-20T20:44:31+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.9
- calibrated_materiality_score: 0.9
- confidence: high
- sec_items: 1.03, 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1001233/000119312526309012/0001193125-26-309012-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1001233/000119312526309012/d125683d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-309012
- JSON: https://secwatch.observer/filing/0001193125-26-309012.json
- Plain text: https://secwatch.observer/filing/0001193125-26-309012.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.